Cargando…
Impact of the 2020 COVID-19 Pandemic on Ambulatory Hepatitis C Testing
INTRODUCTION: Coronavirus disease 2019 (COVID-19) has led to unprecedented modifications to healthcare delivery in the U.S. To preserve resources in preparation for a COVID-19 surge, Boston Medical Center (BMC) implemented workflows to decrease ambulatory in-person visits effective March 16th, 2020....
Autores principales: | Sperring, Heather, Ruiz-Mercado, Glorimar, Schechter-Perkins, Elissa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686585/ https://www.ncbi.nlm.nih.gov/pubmed/33225792 http://dx.doi.org/10.1177/2150132720969554 |
Ejemplares similares
-
HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center
por: Calner, Paul, et al.
Publicado: (2019) -
A collision of crises: Addressing an HIV outbreak among people who inject drugs in the midst of COVID-19
por: Taylor, Jessica L., et al.
Publicado: (2021) -
Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
por: Barocas, Joshua A, et al.
Publicado: (2021) -
Monkeypox Vaccination Strategy and Missed Opportunities in STI and HIV Prevention: An Urban Sexual Health Clinic's Experience During a Public Health Emergency
por: Stewart, Jessica, et al.
Publicado: (2023) -
When Perfect Is the Enemy of Tested: a Call to Scale Rapid HIV Testing for People Who Inject Drugs
por: Alves, Justin, et al.
Publicado: (2022)